Trial Profile
Study of longitudinal tau-PET and atrophy in healthy older adults and Alzheimer's disease
Status:
Completed
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 01 Oct 2018
Price :
$35
*
At a glance
- Drugs Flortaucipir-F-18 (Primary)
- Indications Alzheimer's disease
- Focus Diagnostic use
- 01 Oct 2018 New trial record